BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 25890776)

  • 21. Tumor-stroma ratio predicts prognosis and PD-L1 expression in hepatocellular carcinoma.
    Wang D; Luo J; Tao Y
    BMC Cancer; 2023 May; 23(1):434. PubMed ID: 37173640
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Time of hepatocellular carcinoma recurrence after liver resection and alpha-fetoprotein are important prognostic factors for salvage liver transplantation.
    Lee S; Hyuck David Kwon C; Man Kim J; Joh JW; Woon Paik S; Kim BW; Wang HJ; Lee KW; Suh KS; Lee SK
    Liver Transpl; 2014 Sep; 20(9):1057-63. PubMed ID: 24862741
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Experience of the treatment following downstaging of larger hepatocellular carcinomas by transcathetheter hepatic arterial chemoembolization in 58 patients].
    Jin X; Shi XJ; Wang MQ; Wei LX; Ye HY; Liang YR; Luo Y; Dong JH
    Zhonghua Yi Xue Za Zhi; 2011 Apr; 91(14):950-5. PubMed ID: 21609544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resection or transplantation for early hepatocellular carcinoma in a cirrhotic liver: does size define the best oncological strategy?
    Adam R; Bhangui P; Vibert E; Azoulay D; Pelletier G; Duclos-Vallée JC; Samuel D; Guettier C; Castaing D
    Ann Surg; 2012 Dec; 256(6):883-91. PubMed ID: 23108125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Factors for predicting outcomes of liver transplantation and liver resection for hepatocellular carcinoma meeting Milan criteria].
    Huang J; Zhou J
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Mar; 34(3):406-9. PubMed ID: 24670459
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic factors of disease-free and overall survival in patients with hepatocellular carcinoma undergoing partial hepatectomy in curative intent.
    Lurje G; Bednarsch J; Czigany Z; Amygdalos I; Meister F; Schöning W; Ulmer TF; Foerster M; Dejong C; Neumann UP
    Langenbecks Arch Surg; 2018 Nov; 403(7):851-861. PubMed ID: 30267147
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma.
    Minagawa M; Makuuchi M; Takayama T; Kokudo N
    Ann Surg; 2003 Nov; 238(5):703-10. PubMed ID: 14578733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of inflammation-based prognostic scores as predictors of tumor recurrence in patients with hepatocellular carcinoma after curative resection.
    Yamamura K; Sugimoto H; Kanda M; Yamada S; Nomoto S; Nakayama G; Fujii T; Koike M; Fujiwara M; Kodera Y
    J Hepatobiliary Pancreat Sci; 2014 Sep; 21(9):682-8. PubMed ID: 24823966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stratified neutrophil-to-lymphocyte ratio accurately predict mortality risk in hepatocellular carcinoma patients following curative liver resection.
    Huang GQ; Zhu GQ; Liu YL; Wang LR; Braddock M; Zheng MH; Zhou MT
    Oncotarget; 2016 Feb; 7(5):5429-39. PubMed ID: 26716411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High preoparative levels of serum periostin are associated with poor prognosis in patients with hepatocellular carcinoma after hepatectomy.
    Lv Y; Wang W; Jia WD; Sun QK; Huang M; Zhou HC; Xia HH; Liu WB; Chen H; Sun SN; Xu GL
    Eur J Surg Oncol; 2013 Oct; 39(10):1129-35. PubMed ID: 23916473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Results of salvage liver transplantation.
    Guerrini GP; Gerunda GE; Montalti R; Ballarin R; Cautero N; De Ruvo N; Spaggiari M; Di Benedetto F
    Liver Int; 2014 Jul; 34(6):e96-e104. PubMed ID: 24517642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Minor versus major hepatic resection for small hepatocellular carcinoma (HCC) in cirrhotic patients: a 20-year experience.
    Dahiya D; Wu TJ; Lee CF; Chan KM; Lee WC; Chen MF
    Surgery; 2010 May; 147(5):676-85. PubMed ID: 20004441
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of locoregional therapy before living donor liver transplantation in patients with hepatocellular carcinoma who meet the Milan criteria.
    Kim JM; Kwon CH; Joh JW; Choi MS; Lee JH; Koh KC; Paik SW; Kim GS; Kim SJ; Lee SK; Yoo BC
    Transplant Proc; 2012 Mar; 44(2):403-8. PubMed ID: 22410028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liver transplantation for unresectable hepatocellular carcinoma in normal livers.
    Mergental H; Adam R; Ericzon BG; Kalicinski P; Mühlbacher F; Höckerstedt K; Klempnauer JL; Friman S; Broelsch CE; Mantion G; Fernandez-Sellez C; van Hoek B; Fangmann J; Pirenne J; Muiesan P; Königsrainer A; Mirza DF; Lerut J; Detry O; Le Treut YP; Mazzaferro V; Löhe F; Berenguer M; Clavien PA; Rogiers X; Belghiti J; Kóbori L; Burra P; Wolf P; Schareck W; Pisarski P; Foss A; Filipponi F; Krawczyk M; Wolff M; Langrehr JM; Rolles K; Jamieson N; Hop WC; Porte RJ
    J Hepatol; 2012 Aug; 57(2):297-305. PubMed ID: 22521348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recurrent hepatocellular carcinoma and poorer overall survival in patients undergoing left-sided compared with right-sided partial hepatectomy.
    Valenzuela A; Ha NB; Gallo A; Bonham C; Ahmed A; Melcher M; Kim LH; Esquivel C; Concepcion W; Ayoub WS; Lutchman GA; Daugherty T; Nguyen MH
    J Clin Gastroenterol; 2015 Feb; 49(2):158-64. PubMed ID: 24804988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The clinical behavior of transplantable recurrent hepatocellular carcinoma after curative resection: implications for salvage liver transplantation.
    Lee HS; Choi GH; Joo DJ; Kim MS; Choi JS; Kim SI
    Ann Surg Oncol; 2014 Aug; 21(8):2717-24. PubMed ID: 24916744
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recurrence of hepatocellular carcinoma after liver transplantation: Is there a place for resection?
    Fernandez-Sevilla E; Allard MA; Selten J; Golse N; Vibert E; Sa Cunha A; Cherqui D; Castaing D; Adam R
    Liver Transpl; 2017 Apr; 23(4):440-447. PubMed ID: 28187493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of viral hepatitis on outcomes after liver resection for hepatocellular carcinoma: results from a north american center.
    Lee JJ; Kim PT; Fischer S; Fung S; Gallinger S; McGilvray I; Moulton CA; Wei AC; Greig PD; Cleary SP
    Ann Surg Oncol; 2014 Aug; 21(8):2708-16. PubMed ID: 24806113
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Absolute lymphocyte count recovery at 1 month after transplantation predicts favorable outcomes of patients with hepatocellular carcinoma.
    Zheng Z; Lin B; Zhang J; Yang Z; Xie H; Zhou L; Zhang M; Zheng S
    J Gastroenterol Hepatol; 2015 Apr; 30(4):706-11. PubMed ID: 25238140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Post-transplant infection improves outcome of hepatocellular carcinoma patients after orthotopic liver transplantation.
    Chao JS; Zhao SL; Ou-Yang SW; Qian YB; Liu AQ; Tang HM; Zhong L; Peng ZH; Xu JM; Sun HC
    World J Gastroenterol; 2019 Oct; 25(37):5630-5640. PubMed ID: 31602163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.